🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this trial was is to assess the effect of treatment ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-01-28
Trial ID
NCT01868477
Treatments Being Tested
This study was planned to compare deferasirox and desferrioxamine in terms ...
Status
Completed
Location
Thalassemia Center of Hematology Department, The Children's Hospital & The Institute of Child Health
Start Date
2023-01-01
Trial ID
NCT06468423
Treatments Being Tested
Background: Three iron chelators now available on the market differ in toxi...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT02198508
Treatments Being Tested
This was a randomized, open-label, multicenter, two arm, phase II study to ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-10-21
Trial ID
NCT02435212
Treatments Being Tested
Multicentre, randomised, open label, non-inferiority active-controlled tria...
Status
Completed
Location
Hospital 'Ihsan Çabej'
Start Date
2014-03-17
Trial ID
NCT01825512
Treatments Being Tested
The scientific rationale for this study is the evolving understanding that ...
Status
Terminated
Location
S.O.D. Ematologia Policlino Careggi
Start Date
2019-10-04
Trial ID
NCT03920657
Treatments Being Tested
Assessed the new film-coated tablet formulation to the currently approved d...
Status
Completed
Location
Children's Hospital of Orange County Onc Dept
Start Date
2014-07-08
Trial ID
NCT02125877
Treatments Being Tested
The primary objective of the study is to compare the overall response rate ...
Status
Terminated
Location
Hematology Oncology Services of Arkansas HOSA 2
Start Date
2014-09-11
Trial ID
NCT02159040
Treatments Being Tested
Patients with low-risk MDS verifying the eligibility criteria may be includ...
Status
Completed
Location
CHU de GRENOBLE ALPES
Start Date
2018-02-20
Trial ID
NCT03387475
Treatments Being Tested